期刊文献+

沙培林膀胱灌注对浅表性膀胱移行细胞癌患者血液中血管内皮生长因子的影响 被引量:2

Study on VEGF in blood of the patients with superficial bladder transitional cell carcinoma after perfusion of sapylin
下载PDF
导出
摘要 目的探讨沙培林对浅表性膀胱移行细胞癌患者血液中血管内皮生长因子(vascularendothelialgrowthfactor,VEGF)的影响。方法采用双抗体夹心ELISA法对30例浅表性膀胱移行细胞癌术后患者和15例正常人血液中VEGF的检测,观察浅表性膀胱移行细胞癌患者在沙培林灌注治疗6周后血液中VEGF的变化。结果治疗前患者血液中VEGF水平明显高于对照组;治疗6周后VEGF水平显著降低,但仍较对照组高。结论沙培林膀胱灌注能够显著降低患者血液中VEGF水平,是一种有效的杀死膀胱肿瘤细胞的方法。 Objective To study the expression of the VEGF in blood of the patients with superficial bladder transitional cell carcinoma after perfusion of sapylin.Methods PAP ELISA method was used to study the VEGF in 30 cases of superficial bladder transitional cell carcinoma and in 15 cases of normal people as control.To observe the change of VEGF in blood of the pretherapy and post-perfusion 6 weeks patients with superficial bladder transitional cell carcinoma.Results VEGF level in blood of the patients with superficial bladder transitional cell carcinoma is higher than that of normal people.After 6 weeks perfusion of sapylin,VEGF level in blood decreased obviously,but it is still higher than normal people.Conclusion Perfusion of bladder of sapylin can obviously decrease the level of VEGF in blood.So,it is an effective method to kill the cells of superficial bladder transitional cell carcinoma.
出处 《兰州大学学报(医学版)》 CAS 2005年第2期42-43,50,共3页 Journal of Lanzhou University(Medical Sciences)
关键词 沙培林 膀胱灌注 浅表性膀胱 移行细胞癌 血液 血管内皮生长因子 VEGF sapylin VEGF superficial bladder transitional cell carcinoma perfusion of bladder
  • 相关文献

参考文献9

二级参考文献27

  • 1Benjamin LE, Hemo I, Keshet E, et al. Plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF[J]. Development, 1998, 125(9): 1591-1598.
  • 2Pettersson A, Nagy JA, Brown LF, et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeabillity factor/vascular endothelial growth factor[J]. Lab Invest, 2000, 80(1): 99-115.
  • 3Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption,regression, and growth in tumors mediated by angiopoietins and VEGF[J]. Science, 1999, 284(5422): 1994-1998.
  • 4Zagzag D, Hooper A, Friedlander DR. In Situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis[J]. Exp Neurol, 1999, 159(2):391 - 400.
  • 5Ferrara N, Alitalo K. Applications of angiogenic growth factors and their inhibitors[ J]. Nature Med, 1999,5(11) : 1359 - 1364.
  • 6Dale NW, Yancopoulos GD. Growth factors acting via endothelial cell - specific receptor tyrosine kinases: VEGFs, angiopoietins and ephrins in vascular development[ J ]. Genes Dev, 1999, 13 (9) :1055- 1066.
  • 7Risau W. Mechanisms of angiongenesis [ J ]. Nature, 1997, 386(6626) : 671 - 674.
  • 8Socker S,Takashima S,Miao HQ,et al. Neuropilin-1 is expressed byendothelial and turmr cells as an isform-specific receptor for vascular endothelial growth factor[J]. Cell, 1998, 92(6): 735-745.
  • 9Hiratsuka S, Minowa O,Kuno J,et al. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice[J]. Proc Nail Acade Sci USA, 1998, 95( 16): 9349-9354.
  • 10Taipale J. Makinen T, Arighi E, et al. Vascular endothelial growth factor receptor-3[ J]. Curt Top Microbiol immunol, 1999,237(1):85-96.

共引文献69

同被引文献10

  • 1孙祥宙,邓春华,戴宇平,丘少鹏.沙培林膀胱灌注预防膀胱癌术后复发的机制[J].临床泌尿外科杂志,2004,19(7):407-409. 被引量:15
  • 2吴荣扬,彭善友.膀胱粘膜下注射抗癌药物的实验研究与临床观察[J].中华泌尿外科杂志,1993,14(2):108-110. 被引量:40
  • 3黄宏,林美霞,黄建成,唐华,陈剑.经尿道电气化加吡柔比星粘膜下注射治疗浅表性膀胱肿瘤的临床观察[J].国外医学(泌尿系统分册),2005,25(4):572-574. 被引量:2
  • 4Nakayama F,wagaki H, Gouchi A, et al. Effect of streptococcal lyzate OK- 432 on peripheral blood mononuclear cells in gastric cancer patients[J]. J Med, 1998,29 : 199 - 215.
  • 5Yamamoto K,Tanaka R, Yoshida S, et al. Effects of OK -432 on the proliferation and cytotoxicity of lymphokine - activated killer(LAK) cells[ J ]. J Immunother, 1999, 22:33 - 40.
  • 6吴阶平,尿路上皮肿瘤概论[M].吴阶平泌尿外科学.2004,919-943.
  • 7Nieder A M, Simon M A, Kim S S, et al. Radical cystectomy after bacillus calmetter- guerin for high risk Ta, T1 , and carcinoma in situ : defining the risk of initial bladder preservation. Urology, 2006,67 (4) :737 - 741.
  • 8Lamm DL, Dehaven Jl, Riggs DR. Keyhole limpet hemocyanin im- munotherapy of bladder cancer: la- Boratory and clinical studies. Eur urol,2000,37 (suppl) :40 - 44.
  • 9Yamaguchi Y, Miyahara E, Ohshita A, et al. locore - gional immu- notherapy of malignant effusion from color - ectal cancer using the streptococcal preparation OK -432 plus interleukin -2 induction of autologous tumor reactive CD4 + Thl killer lymphocytes. Br JCancer, 2003,89 : 1876 - 1884.
  • 10杨荣辰,包国荣,武艳华,杨继旭,刘剑昌,韩明辉,司晓东.沙培林膀胱内灌注预防膀胱癌术后复发的临床研究[J].中原医刊,2008,35(7):51-52. 被引量:1

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部